CloudMD (TSXV:DOC): The Next WELL Health (TSX:WELL) Stock?

CloudMD (TSXV:DOC) stock has the potential to become one of Canada’s most lucrative telehealth opportunities.

| More on:
healthcare pharma

Image source: Getty Images

If you invested in WELL Health Technologies (TSX:WELL) in 2016, your capital would be worth over 7.6 times as much by now. The telehealth startup has been one of the most successful technology startups in Canada. Now, another emerging startup, CloudMD Software & Services Inc. (TSX:DOC) stock could be on the same course. 

CloudMD stock has already delivered a 330% return since going public in June. That’s better than WELL stock’s return over the same period: 196%. In other words, savvy investors who jumped into this stock early have outpaced Canada’s most noteworthy healthtech startup during this crisis. 

Can CloudMD stock sustain this incredible run? Is it better than WELL Health? Here’s a closer look. 

Telehealth outlook

There’s plenty of room for more than one telehealth giant. This industry is simply so nascent and offers so much potential for growth, that I wouldn’t be surprised if we had even more telehealth startups emerge over the next few years. 

The global telehealth market is expected to double from US$25 billion (C$32.9 billion) this year to over US$55.6 billion (C$73.26 billion) by 2025. Even then, telehealth has barely scratched the surface of global healthcare – a multi-trillion dollar industry. 

Meanwhile, WELL stock and CloudMD stock are worth $1.16 billion and $326 million respectively. They both have plenty of potential to capture market share as more people adopt virtual clinic sessions and mobile consultations over the next decade. However, if you’re trying to choose the better option between these two, you might want to dig into their fundamentals.

CloudMD stock valuation

Like any other startup, CloudMD isn’t profitable yet. Instead, the company’s valuation relies on its revenue and growth rate. CloudMD stock is currently trading at a price-to-sales ratio of 31.2. By comparison, WELL stock is trading at a P/S ratio of 30.4. In other words, the startup’s valuation is justified based on trailing sales. 

However, WELL Health has some clear advantages over its smaller rival. The company has recently entered the United States, which is the largest telehealth market in the world. The company is also three year older, has more doctors, more software clients and a wide network of physical clinics that sets it apart from the competition. 

I would argue that exposure to the United States and funding from Hong Kong billionaire Li Ka-Shing puts WELL Health in a better position to grow over the long term. Based on this assumption, WELL stock is clearly a better option for growth-seeking investors. 

Bottom line

CloudMD stock has the potential to become one of Canada’s most lucrative telehealth opportunities. It’s only the second pure-play virtual health startup that’s publicly listed. The first, WELL Health, has already delivered stunning returns over the past four years. 

However, I believe the larger, older company is better positioned for growth over the long term. While both stocks have the potential to deliver multibagger gains, WELL Health is my preferred option.  

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani owns shares of WELL.

More on Tech Stocks

tech and analysis
Tech Stocks

2 Top Tech Stocks Investors Should Consider Buying Right Now

Tech stocks such as Sierra Wireless and Open Text are well positioned to deliver outsized gains to investors in 2022…

Read more »

cup of cappuccino with a sad face
Tech Stocks

Shopify (TSX:SHOP) Stock Has Been a Bloodbath

The share price of the TSX’s tech phenomenon could still plunge if the bloodbath continues due to the slowdown of…

Read more »

sad concerned deep in thought
Tech Stocks

Tech Stocks Crumble: Is it Time to Buy?

Shopify is coming down from its pandemic highs as its business falters, but BlackBerry's business is just gaining steam.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Tech Stocks

This 1 High-Growth Stock Just Got Irresistible

Despite a challenging macro environment, Lightspeed continues to post strong growth, which could help this high-growth stock stage a sharp…

Read more »

exchange-traded funds
Tech Stocks

Buy the Dip: 3 ETFs That Have Taken a Beating in 2022

Three prominent TSX ETFs trades at bargain prices in 2022 because of their significant exposure to the slumping technology sector.

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Tech Stocks

Lightspeed Stock Gains 10% Post Q4 Results

Lightspeed stock gained on the back of stellar results in Q4 of fiscal 2022. Should LSPD stock be part of…

Read more »

Man data analyze
Tech Stocks

Tech Selloff: 3 Growth Stocks Available at Pre-COVID-19 Prices

Tech stocks such as Shopify and Zoom are trading at a much lower multiple due to the ongoing selloff in…

Read more »

TSX Today
Tech Stocks

TSX Today: What to Watch for in Stocks on Friday, May 20

The ongoing strength in the commodity market could help TSX Composite to continue outperforming its U.S. peers in the near…

Read more »